Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets.
Sign Up to like & getrecommendations! Published in 2022 at "Current cancer drug targets"
DOI: 10.2174/1568009622666220419122716
Abstract: Chordoma is a rare, slow-growing sarcoma that is locally aggressive, and typically resistant to conventional chemo- and radiotherapies. Despite its low incidence, chordoma remains a clinical challenge because therapeutic options for chordoma are limited, and… read more here.
Keywords: chordoma prognostic; prognostic markers; dysregulated epigenetics; markers therapeutic ... See more keywords